Table 2.

Predictors of Early Continence Recovery After RP

Characteristic	Univariate		Multivariate
	ORa (95% CIa)	P Value	Adjusted OR (95% CI)	P Value
Patient age (y)
<50	1.0 (reference)	—	1.0 (reference)	—
51–64	0.30 (0.08–1.09)	.07	0.38 (0.10–1.52)	.17
≥65	0.24 (0.06–0.93)	.04	0.37 (0.09–1.59)	.18
BMIa (kg/m2)
<30	1.0 (reference)	—	1.0 (reference)	—
≥30	0.80 (0.39–1.63)	.53	0.89 (0.40–1.98)	.78
PSAa (ng/mL)
<10	1.0 (reference)	—	1.0 (reference)	—
≥10	0.92 (0.40–2.12)	.85	1.03 (0.36–2.90)	.96
Gleason score
6	1.0 (reference)	—	1.0 (reference)	—
≥7	0.81 (0.44–1.49)	.50	0.61 (0.28–1.36)	.23
Surgeon experience (cases)
≤50	1.0 (reference)	—	1.0 (reference)	—
51–100	1.65 (0.74–3.71)	.22	1.69 (0.60–4.79)	.32
101–150	1.51 (0.68–3.38)	.31	1.27 (0.44–3.66)	.66
151–175	1.81 (0.66–4.96)	.25	1.21 (0.36–4.15)	.76
MLE
No	1.0 (reference)	—	1.0 (reference)	—
Yes	0.34 (0.16–0.73)	.005	0.32 (0.13–0.81)	.02
Bladder neck sparing
No	1.0 (reference)	—	1.0 (reference)	—
Yes	1.60 (0.86–2.97)	.13	1.53 (0.74–3.20)	.25
Posterior reconstruction
No	1.0 (reference)	—	1.0 (reference)	—
Yes	0.67 (0.23–1.93)	.46	0.76 (0.18–3.18)	.71
Potency nerve sparing
None	1.0 (reference)	—	1.0 (reference)	—
Unilateral	1.07 (0.42–2.70)	.89	0.93 (0.31–2.75)	.90
Bilateral	1.55 (0.71–3.35)	.27	1.20 (0.43–3.35)	.73
Prostate weight (g)
<50	1.14 (0.61–2.13)	.69	0.69 (0.31–1.55)	.38
50–79.9	1.0 (reference)	—	1.0 (reference)	—
≥80	0.80 (0.20–3.21)	.75	1.20 (0.22–6.55)	.84
Pathologic stage
pT2x	1.0 (reference)	—	1.0 (reference)	—
pT3x	1.26 (0.57–2.81)	.56	1.51 (0.58–3.91)	.40

^aBMI = body mass index; CI = confidence interval; OR, odds ratio; PSA = prostate-specific antigen.